Na tej stronie
CNMD CONMED Corporation Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 6, 2026 10-K/10-Q Lip 29, 2026
$44,48
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$31,4452tyg. minimum
$53,6652tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$1.39B
P/E (TTM)
24.0
EPS (TTM)
$1.85
Przychody (TTM)
$1.37B
Twoje odznaki
Zakres 52 tyg.
$31–$54
Ocena Analityków
HOLD
Cena Docelowa
$46
P/E
24.0
ROE
5.5%
Marża Zysku Netto
4.1%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
CNMD Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$44.48
Kapitalizacja Rynkowa (MRQ)
$1.39B
P/E (TTM)
24.0
EPS (TTM)
$1.85
Przychody (TTM)
$1.37B
Stopa dywidendy
1.8%
ROE (TTM)
5.5%
Zakres 52 tyg.
$31–$54
CNMD Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 10 września 2001 | 3-for-2 | Naprzód |
| 1 grudnia 1995 | 3-for-2 | Naprzód |
| 28 grudnia 1994 | 3-for-2 | Naprzód |
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$1.37B2016-12-31 → 2025-12-31
EPS$1.512016-12-31 → 2025-12-31
Wolny przepływ pieniężny$151M2016-12-31 → 2025-12-31
Marża netto4.1%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | CNMD | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 24.0średnia z 5 lat ≈27.3 | ≈27.3 | 33.6 | Niedowartościowany | |
| P/S (TTM) | 1.0średnia z 5 lat ≈2.5 | ≈2.5 | 2.4 | Niedowartościowany | |
| P/B (MRQ) | 1.3średnia z 5 lat ≈3.4 | ≈3.4 | 4.4 | Niedowartościowany | |
| Cena / FCF (TTM) | 10.4średnia z 5 lat ≈68.0 | ≈68.0 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 9.2średnia z 5 lat ≈34.1 | ≈34.1 | 26.2 | Niedowartościowany | |
| Cena / Wartość księgowa materialna (MRQ) | 2.9 | · | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈0.7 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | CNMD | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 55.8%średnia z 5 lat ≈55.2% | ≈55.2% | 60.8% | Zgodnie z | |
| Marża Operacyjna (TTM) | 8.0%średnia z 5 lat ≈10.0% | ≈10.0% | 10.4% | Zgodnie z | |
| EBITDA Margin (Marża EBITDA) | 7.5%średnia z 5 lat ≈10.0% | ≈10.0% | 10.6% | Zgodnie z | |
| Marża przed opodatkowaniem (TTM) | 6.1%średnia z 5 lat ≈4.9% | ≈4.9% | 9.1% | Zgodnie z | |
| Marża Zysku Netto (TTM) | 4.1%średnia z 5 lat ≈3.4% | ≈3.4% | 6.7% | Zgodnie z | |
| ROA (TTM) | 2.4%średnia z 5 lat ≈2.0% | ≈2.0% | 1.2% | Najwyższa półka | |
| ROE (TTM) | 5.5%średnia z 5 lat ≈4.7% | ≈4.7% | 2.2% | Najwyższa półka | |
| ROIC | 6.6%średnia z 5 lat ≈11.5% | ≈11.5% | 3.4% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | CNMD | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 1.5średnia z 5 lat ≈2.1 | ≈2.1 | 3.2 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.8średnia z 5 lat ≈0.8 | ≈0.8 | 1.6 | Niska płynność | |
| Interest Coverage (Pokrycie odsetek) | 3.3średnia z 5 lat ≈3.4 | ≈3.4 | 3.3 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | CNMD | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 5.2%średnia z 5 lat ≈10.0% | ≈10.0% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 9.6%średnia z 5 lat ≈10.5% | ≈10.5% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 9.8% | · | · | · | |
| EPS YoY | -64.5%średnia z 5 lat ≈183.4% | ≈183.4% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -64.5%średnia z 5 lat ≈199.4% | ≈199.4% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 29.9% | · | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 36.4% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 28.4% | · | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 37.7% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | CNMD | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.6średnia z 5 lat ≈0.6 | ≈0.6 | 0.6 | Zgodnie z | |
| Inventory Turnover (Rotacja zapasów) | 1.8średnia z 5 lat ≈1.8 | ≈1.8 | 1.8 | Słaby | |
| Receivables Turnover (Rotacja należności) | 5.7średnia z 5 lat ≈5.6 | ≈5.6 | 6.9 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$352.5K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy1.8%
Wskaźnik Wypłaty Dywidendy52.6%
Zannualizowane wypłaty≈$0.80
CAGR dywidendy 5-letni≈0.00%
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Wrz 15, 2025 | $0,20 | USD | ≈1.5% |
| Cze 13, 2025 | $0,20 | USD | ≈1.5% |
| Mar 14, 2025 | $0,20 | USD | ≈1.4% |
| Gru 20, 2024 | $0,20 | USD | ≈1.2% |
| Wrz 16, 2024 | $0,20 | USD | ≈1.1% |
| Cze 14, 2024 | $0,20 | USD | ≈1.1% |
| Mar 14, 2024 | $0,20 | USD | ≈1.0% |
| Gru 15, 2023 | $0,20 | USD | ≈0.71% |
| Wrz 14, 2023 | $0,20 | USD | ≈0.74% |
| Cze 14, 2023 | $0,20 | USD | ≈0.59% |
| Mar 14, 2023 | $0,20 | USD | ≈0.86% |
| Gru 15, 2022 | $0,20 | USD | ≈0.93% |
| Wrz 14, 2022 | $0,20 | USD | ≈0.86% |
| Cze 14, 2022 | $0,20 | USD | ≈0.86% |
| Mar 14, 2022 | $0,20 | USD | ≈0.59% |
| Gru 14, 2021 | $0,20 | USD | ≈0.60% |
| Wrz 14, 2021 | $0,20 | USD | ≈0.64% |
| Cze 14, 2021 | $0,20 | USD | ≈0.58% |
| Mar 12, 2021 | $0,20 | USD | ≈0.64% |
| Gru 14, 2020 | $0,20 | USD | ≈0.76% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
8.4%
Następny raport
Lis 03, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 28, 2026 | $1.38 | $1.13 | 21.8% |
| 31 marca 2026 | $0.89 | $0.84 | 6.5% | |
| 31 grudnia 2025 | $1.43 | $1.35 | 5.9% | |
| 30 września 2025 | $1.08 | $1.07 | 0.66% | |
| 30 czerwca 2025 | $1.15 | $1.15 | 0.37% | |
| 31 marca 2025 | $0.95 | $0.83 | 14.8% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B | $862M | $955M | $860M | $796M | $764M | $719M | $740M | |
| Cost of Revenue | $624M | $574M | $568M | $474M | $443M | $402M | $430M | $391M | $365M | $355M | $337M | $336M | |
| Gross Profit | $750M | $733M | $676M | $571M | $568M | $460M | $525M | $469M | $431M | $408M | $382M | $404M | |
| R&D Expense | $56M | $54M | $53M | $47M | $44M | $40M | $45M | $42M | $32M | $32M | $27M | $28M | |
| SG&A Expense | $592M | $478M | $503M | $454M | $415M | $374M | $400M | $356M | $352M | $338M | $303M | $323M | |
| Operating Expenses | $648M | $533M | $556M | $501M | $458M | $414M | $446M | $398M | $384M | $371M | $331M | $351M | |
| Operating Income | $103M | $200M | $121M | $70M | $110M | $46M | $79M | $71M | $47M | $38M | $51M | $53M | |
| Interest Expense | $31M | $37M | $40M | $29M | $35M | $44M | $43M | $21M | $18M | $15M | $6M | $6M | |
| Pretax Income | $71M | $163M | $81M | $-71M | $73M | $2M | $31M | $51M | $29M | $19M | $45M | $47M | |
| Income Tax | $24M | $31M | $16M | $10M | $11M | $-8M | $3M | $10M | $-27M | $5M | $15M | $14M | |
| Net Income | $47M | $132M | $64M | $-81M | $63M | $10M | $29M | $41M | $55M | $15M | $30M | $32M | |
| EPS (Basic) | $1.52 | $4.29 | $2.10 | $-2.68 | $2.14 | $0.33 | $1.01 | $1.45 | $1.99 | $0.53 | $1.10 | $1.17 | |
| EPS (Diluted) | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 | $0.32 | $0.97 | $1.41 | $1.97 | $0.52 | $1.09 | $1.16 | |
| Shares (Basic) | 31,036,000 | 30,846,000 | 30,668,000 | 30,040,000 | 29,162,000 | 28,581,000 | 28,325,000 | 28,118,000 | 27,939,000 | 27,804,000 | 27,653,000 | 27,401,000 | |
| Shares (Diluted) | 31,149,000 | 31,150,000 | 31,548,000 | 30,040,000 | 32,216,000 | 29,464,000 | 29,495,000 | 28,890,000 | 28,171,000 | 27,964,000 | 27,858,000 | 27,769,000 | |
| EBITDA | $103M | $200M | $121M | $70M | $110M | $46M | $79M | $71M | $47M | $38M | $51M | $53M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | $26M | $18M | $33M | $27M | $73M | $66M | |
| Receivables | $248M | $238M | $242M | $191M | $184M | $177M | $189M | $182M | $167M | $148M | $134M | $129M | |
| Inventory | $356M | $347M | $318M | $332M | $232M | $195M | $165M | $155M | $141M | $136M | $133M | $148M | |
| Prepaid Expense | $29M | $31M | $31M | $29M | $24M | $17M | $18M | $21M | $16M | $19M | $20M | $22M | |
| Current Assets | $673M | $640M | $616M | $581M | $460M | $417M | $397M | $374M | $357M | $331M | $360M | $381M | |
| PP&E (Net) | $113M | $116M | $121M | $116M | $109M | $111M | $119M | $113M | $116M | $122M | $125M | $133M | |
| PP&E (Gross) | $430M | $421M | $413M | $393M | $373M | $357M | $347M | $332M | $323M | $308M | $293M | $298M | |
| Accum. Depreciation | $317M | $305M | $292M | $278M | $264M | $246M | $228M | $219M | $207M | $186M | $168M | $164M | |
| Goodwill | $807M | $805M | $807M | $815M | $618M | $618M | $618M | $400M | $402M | $398M | $261M | $256M | |
| Intangibles | $582M | $618M | $649M | $682M | $471M | $502M | $533M | $413M | $415M | $420M | $308M | $316M | |
| Other Non-current Assets | $150M | $116M | $96M | $94M | $99M | $104M | $108M | $68M | $68M | · | · | · | |
| Total Assets | $2.33B | $2.31B | $2.30B | $2.30B | $1.77B | $1.75B | $1.78B | $1.37B | $1.36B | $1.33B | $1.10B | $1.10B | |
| Accounts Payable | $94M | $102M | $88M | $73M | $58M | $53M | $56M | $53M | $42M | $42M | $35M | $24M | |
| Current Liabilities | $315M | $278M | $311M | $297M | $197M | $190M | $188M | $161M | $150M | $114M | $120M | $116M | |
| Capital Leases | $44M | $33M | $10M | $12M | $13M | $15M | $17M | · | · | · | · | · | |
| Deferred Tax | $80M | $74M | $61M | $67M | $69M | $58M | $74M | $81M | $78M | $119M | $103M | $112M | |
| Other Non-current Liabilities | $64M | $86M | $121M | $204M | $43M | $59M | $47M | $26M | $27M | $27M | $24M | $49M | |
| Total Liabilities | $1.29B | $1.34B | $1.47B | $1.55B | $981M | $1.04B | $1.06B | $707M | $727M | $748M | $517M | $517M | |
| Long-term Debt | · | · | · | · | · | · | · | $457M | $486M | $498M | $271M | $241M | |
| Total Debt | · | · | · | · | · | · | · | $457M | $486M | $498M | $271M | $241M | |
| Common Stock | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | |
| Paid-in Capital | $503M | $477M | $447M | $413M | $397M | $383M | $379M | $342M | $334M | $329M | $325M | $320M | |
| Retained Earnings | $589M | $560M | $453M | $413M | $497M | $457M | $471M | $465M | $440M | $407M | $415M | $406M | |
| Treasury Stock | $13M | $16M | $15M | $23M | $54M | $68M | $81M | $89M | $94M | $97M | $101M | $105M | |
| AOCI | $-46M | $-59M | $-50M | $-58M | $-54M | $-64M | $-59M | $-56M | $-49M | $-59M | $-54M | $-40M | |
| Stockholders' Equity | $1.03B | $963M | $834M | $746M | $785M | $709M | $710M | $662M | $631M | $581M | $585M | $581M | |
| Liabilities + Equity | $2.33B | $2.31B | $2.30B | $2.30B | $1.77B | $1.75B | $1.78B | $1.37B | $1.36B | $1.33B | $1.10B | $1.10B | |
| Shares Outstanding | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $26M | $24M | $22M | $16M | $13M | $12M | $10M | $8M | $8M | $7M | $9M | |
| Deferred Tax | $4M | $12M | $700.0K | $-6M | $3M | $-14M | $-6M | $2M | $-40M | $-3M | $2M | $-284.0K | |
| Amort. of Intangibles | $35M | $35M | $35M | $34M | $33M | $34M | $32M | $23M | $21M | $20M | $13M | $13M | |
| Restructuring | · | · | · | · | · | · | · | · | $4M | $10M | $22M | $22M | |
| Operating Cash Flow | $171M | $167M | $125M | $33M | $112M | $65M | $95M | $75M | $66M | $40M | $51M | $65M | |
| CapEx | $20M | $13M | $19M | $22M | $15M | $13M | $20M | $17M | $13M | $15M | $15M | $15M | |
| Investing Cash Flow | $-21M | $-13M | $-20M | $-250M | $-15M | $-14M | $-388M | $-17M | $-29M | $-266M | $-24M | $-21M | |
| Debt Issued | · | · | · | · | · | · | $265M | $0 | $0 | $175M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $111M | $-13M | $-9M | $166M | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $0 | $0 | $17M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | $0 | $-17M | |
| Dividends Paid | $25M | $25M | $25M | $24M | $23M | $23M | $23M | $22M | $22M | $22M | $22M | $22M | |
| Financing Cash Flow | $-136M | $-151M | $-110M | $225M | $-102M | $-52M | $301M | $-72M | $-35M | $183M | $-13M | $-26M | |
| Net Change in Cash | $16M | $163.0K | $-5M | $8M | $-7M | $2M | $8M | $-15M | $5M | $-45M | $6M | $12M | |
| Taxes Paid | $21M | $17M | $19M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $151M | $154M | $106M | $12M | $97M | $52M | $75M | $58M | $53M | $23M | $33M | $50M | |
| Levered FCF | $130M | $124M | $75M | $-21M | $67M | $-210M | $36M | $42M | $18M | $12M | $29M | $46M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.6% | 56.1% | 54.3% | 54.6% | 56.2% | 53.4% | 54.9% | 54.6% | 54.1% | 53.5% | 53.1% | 54.6% | |
| Operating Margin | 7.5% | 15.3% | 9.7% | 6.7% | 10.9% | 5.3% | 8.3% | 8.3% | 5.9% | 4.9% | 7.1% | 7.1% | |
| Net Margin | 3.4% | 10.1% | 5.2% | -7.7% | 6.2% | 1.1% | 3.0% | 4.8% | 7.0% | 1.9% | 4.2% | 4.3% | |
| Pretax Margin | 5.2% | 12.5% | 6.5% | -6.8% | 7.2% | 0.19% | 3.3% | 5.9% | 3.6% | 2.5% | 6.3% | 6.3% | |
| EBITDA Margin | 7.5% | 15.3% | 9.7% | 6.7% | 10.9% | 5.3% | 8.3% | 8.3% | 5.9% | 4.9% | 7.1% | 7.1% | |
| ROA | 2.0% | 5.8% | 2.8% | -4.0% | 3.6% | 0.54% | 1.8% | 3.0% | 4.1% | 1.2% | 2.8% | 2.9% | |
| ROE | 4.6% | 14.0% | 7.9% | -11.0% | 8.1% | 1.4% | 4.1% | 6.2% | 9.2% | 2.5% | 5.2% | 5.4% | |
| ROIC | 6.6% | 16.9% | 11.5% | 10.7% | 11.9% | 38.5% | 10.2% | 5.1% | 8.1% | 2.6% | 4.0% | 4.4% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.3 | 2.0 | 2.0 | 2.3 | 2.2 | 2.1 | 2.3 | 2.4 | 2.9 | 3.4 | 3.3 | |
| Quick Ratio | 0.8 | 0.9 | 0.8 | 0.6 | 0.9 | 0.9 | 1.1 | 1.2 | 1.3 | 1.5 | 1.7 | 1.7 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.7 | 0.8 | 0.9 | 0.5 | 0.4 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.7 | 0.7 | 0.8 | 0.5 | 0.4 | |
| Interest Coverage | 3.3 | 5.4 | 3.0 | 2.4 | 3.1 | 1.0 | 1.9 | 3.5 | 2.6 | 2.5 | 8.5 | 8.6 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.5 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.8 | 1.7 | 1.7 | 1.7 | 2.1 | 2.2 | 2.7 | 2.6 | 2.6 | 2.6 | 2.1 | 2.3 | |
| Receivables Turnover | 5.7 | 5.4 | 5.7 | 5.6 | 5.6 | 4.7 | 5.2 | 4.9 | 5.1 | 5.4 | 5.5 | 5.5 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.01 | $30.76 | $26.65 | $23.82 | $25.09 | $22.65 | $22.70 | $21.16 | $20.17 | $18.55 | $18.69 | $18.57 | |
| Revenue / Share | $44.13 | $41.96 | $39.46 | $34.80 | $31.37 | $29.27 | $32.38 | $29.76 | $28.27 | $27.30 | $25.82 | $26.65 | |
| Cash Flow / Share | $5.48 | $5.36 | $3.97 | $1.11 | $3.47 | $2.19 | $3.23 | $2.59 | $2.33 | $1.37 | $1.73 | $2.35 | |
| Cash / Share | · | · | · | · | · | · | $0.83 | $0.56 | $1.04 | $0.88 | $2.32 | $2.12 | |
| Dividend / Share | $0.60 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | |
| EPS (TTM) | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 | $0.32 | $0.97 | $1.41 | $1.97 | $0.52 | $1.09 | $1.16 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.2% | 5.0% | 19.1% | 3.5% | 17.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.6% | 8.9% | 13.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -64.5% | 108.3% | · | · | 506.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 29.9% | 85.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 36.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -64.5% | 105.4% | · | · | 557.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 28.4% | 89.2% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 37.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 1.6% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B | $862M | $955M | $860M | $796M | $764M | $719M | $740M | |
| Net Income TTM | $47M | $132M | $64M | $-81M | $63M | $10M | $29M | $41M | $55M | $15M | $30M | $32M | |
| Market Cap | $1.27B | $2.14B | $3.43B | $2.77B | $4.44B | $3.51B | $3.50B | $2.01B | $1.60B | $1.38B | $1.38B | $1.41B | |
| Enterprise Value | · | · | · | · | · | · | · | $2.45B | $2.05B | $1.85B | $1.58B | $1.58B | |
| P/E | 26.9 | 16.1 | 53.7 | -33.1 | 73.1 | 350.0 | 115.3 | 45.5 | 25.9 | 84.9 | 40.4 | 38.8 | |
| P/S | 0.9 | 1.6 | 2.8 | 2.7 | 4.4 | 4.1 | 3.7 | 2.3 | 2.0 | 1.8 | 1.9 | 1.9 | |
| P/B | 1.2 | 2.2 | 4.1 | 3.7 | 5.6 | 4.9 | 4.9 | 3.0 | 2.5 | 2.4 | 2.4 | 2.4 | |
| P / Cash Flow | 7.4 | 12.8 | 27.3 | 83.2 | 39.7 | 54.3 | 36.8 | 26.9 | 24.3 | 36.2 | 28.7 | 21.6 | |
| P / FCF | 8.4 | 13.9 | 32.2 | 239.6 | 45.8 | 68.0 | 46.6 | 34.5 | 30.3 | 58.9 | 41.7 | 28.3 | |
| EV / EBITDA | · | · | · | · | · | · | · | 34.3 | 43.7 | 49.2 | 30.8 | 30.0 | |
| EV / FCF | · | · | · | · | · | · | · | 42.1 | 38.9 | 79.0 | 47.7 | 31.8 | |
| EV / Revenue | · | · | · | · | · | · | · | 2.8 | 2.6 | 2.4 | 2.2 | 2.1 | |
| Dividend Yield | 1.9% | 1.1% | 0.71% | 0.86% | 0.52% | 0.65% | 0.65% | 1.1% | 1.4% | 1.6% | 1.6% | 1.6% | |
| Earnings Yield | 3.7% | 6.2% | 1.9% | -3.0% | 1.4% | 0.29% | 0.87% | 2.2% | 3.9% | 1.2% | 2.5% | 2.6% | |
| Payout Ratio | 52.6% | 18.6% | 38.0% | -29.7% | 37.2% | 239.8% | 79.0% | 54.9% | 40.2% | 151.5% | 72.5% | 68.2% | |
| Annual Payout | $25M | $25M | $25M | $24M | $23M | $23M | $23M | $22M | $22M | $22M | $22M | $22M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $343M | $317M | $373M | $338M | $342M | $321M | $346M | $317M | $332M | $312M | $327M | $305M | $318M | $295M | $251M | $275M | |
| Cost of Revenue | $146M | $134M | $155M | $172M | $154M | $144M | $148M | $138M | $148M | $140M | $145M | $137M | $147M | $140M | $119M | $123M | |
| Gross Profit | $197M | $183M | $218M | $166M | $188M | $178M | $198M | $179M | $184M | $172M | $182M | $168M | $171M | $155M | $132M | $152M | |
| R&D Expense | $16M | $16M | $15M | $14M | $14M | $13M | $13M | $14M | $14M | $14M | $14M | $12M | $14M | $13M | $12M | $13M | |
| SG&A Expense | $146M | $142M | $167M | $140M | $136M | $149M | $133M | $100M | $123M | $123M | $118M | $125M | $130M | $130M | $121M | $115M | |
| Operating Expenses | $161M | $158M | $182M | $154M | $150M | $162M | $146M | $113M | $137M | $137M | $132M | $138M | $143M | $143M | $133M | $127M | |
| Operating Income | $36M | $25M | $37M | $12M | $38M | $16M | $52M | $66M | $47M | $35M | $50M | $30M | $27M | $13M | $-1M | $24M | |
| Interest Expense | $8M | $7M | $7M | $8M | $8M | $8M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | |
| Other Non-op | $3M | · | · | · | $-418.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $31M | $18M | $29M | $4M | $30M | $8M | $44M | $56M | $38M | $25M | $41M | $20M | $17M | $2M | $-11M | $16M | |
| Income Tax | $8M | $5M | $13M | $1M | $8M | $2M | $10M | $7M | $8M | $6M | $8M | $4M | $4M | $625.0K | $-37M | $-30M | |
| Net Income | $23M | $14M | $17M | $3M | $21M | $6M | $34M | $49M | $30M | $20M | $33M | $16M | $14M | $2M | $27M | $46M | |
| EPS (Basic) | $0.77 | $0.45 | $0.55 | $0.09 | $0.69 | $0.19 | $1.09 | $1.59 | $0.97 | $0.64 | $1.07 | $0.52 | $0.45 | $0.06 | $0.95 | $1.51 | |
| EPS (Diluted) | $0.77 | $0.45 | $0.54 | $0.09 | $0.69 | $0.19 | $1.09 | $1.57 | $0.96 | $0.63 | $1.05 | $0.50 | $0.43 | $0.06 | $1.02 | $1.48 | |
| Shares (Basic) | 30,069,000 | 30,588,000 | · | 30,955,000 | 30,949,000 | 30,973,000 | · | 30,856,000 | 30,813,000 | 30,780,000 | · | 30,741,000 | 30,662,000 | 30,511,000 | · | 30,473,000 | |
| Shares (Diluted) | 30,117,000 | 30,621,000 | · | 31,050,000 | 31,054,000 | 31,151,000 | · | 31,112,000 | 31,106,000 | 31,272,000 | · | 31,689,000 | 31,795,000 | 31,204,000 | · | 31,103,000 | |
| EBITDA | $36M | $25M | · | $12M | $38M | $16M | · | $66M | $47M | $35M | · | $30M | $27M | $13M | · | $24M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $240M | $229M | $248M | $225M | $234M | $221M | $238M | $231M | $239M | $241M | · | $230M | $229M | $213M | · | $197M | |
| Inventory | $360M | $366M | $356M | $364M | $362M | $355M | $347M | $343M | $322M | $322M | · | $326M | $327M | $335M | · | $305M | |
| Prepaid Expense | $38M | $41M | $29M | $34M | $27M | $28M | $31M | $29M | $33M | $38M | · | $39M | $31M | $35M | · | $39M | |
| Current Assets | $676M | $671M | $673M | $662M | $658M | $639M | $640M | $641M | $624M | $636M | · | $626M | $616M | $610M | · | $574M | |
| PP&E (Net) | $110M | $112M | $113M | $112M | $117M | $116M | $116M | $117M | $117M | $118M | · | $120M | $117M | $115M | · | $114M | |
| PP&E (Gross) | · | · | $430M | · | · | · | $421M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $317M | · | · | · | $305M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $797M | $807M | $807M | $807M | $807M | $806M | $805M | $807M | $806M | $806M | $807M | $815M | $816M | $815M | $815M | $814M | |
| Intangibles | $564M | $574M | $582M | $593M | $602M | $610M | $618M | $626M | $633M | $641M | · | $657M | $666M | $674M | · | $689M | |
| Other Non-current Assets | $153M | $152M | $137M | $148M | $145M | $127M | $116M | $125M | $105M | $108M | · | $107M | $109M | $106M | · | $100M | |
| Total Assets | $2.30B | $2.31B | $2.33B | $2.32B | $2.33B | $2.30B | $2.31B | $2.32B | $2.29B | $2.31B | · | $2.33B | $2.32B | $2.32B | · | $2.29B | |
| Accounts Payable | $101M | $105M | $94M | $107M | $101M | $96M | $102M | $105M | $101M | $102M | · | $82M | $79M | $77M | · | $74M | |
| Current Liabilities | $455M | $293M | $315M | $315M | $295M | $283M | $278M | $282M | $266M | $291M | · | $376M | $353M | $321M | · | $209M | |
| Capital Leases | · | · | $44M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $85M | $81M | $80M | $75M | $70M | $70M | $74M | $66M | $65M | $64M | · | $67M | $66M | $66M | · | $113M | |
| Other Non-current Liabilities | $62M | $63M | $64M | $72M | $80M | $76M | $86M | $95M | $107M | $109M | · | $144M | $152M | $186M | · | $218M | |
| Total Liabilities | $1.26B | $1.30B | $1.29B | $1.31B | $1.33B | $1.32B | $1.34B | $1.38B | $1.40B | $1.45B | · | $1.53B | $1.54B | $1.57B | · | $1.58B | |
| Common Stock | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | $313.0K | · | $313.0K | $313.0K | $313.0K | · | $313.0K | |
| Paid-in Capital | $513M | $508M | $503M | $499M | $494M | $489M | $477M | $471M | $465M | $458M | · | $440M | $433M | $420M | · | $407M | |
| Retained Earnings | $626M | $603M | $589M | $572M | $575M | $560M | $560M | $533M | $490M | $466M | · | $426M | $416M | $408M | · | $392M | |
| Treasury Stock | $55M | $49M | $13M | $14M | $14M | $15M | $16M | $16M | $19M | $20M | · | $15M | $16M | $21M | · | $23M | |
| AOCI | $-43M | $-45M | $-46M | $-49M | $-53M | $-57M | $-59M | $-55M | $-54M | $-50M | · | $-54M | $-53M | $-55M | · | $-60M | |
| Stockholders' Equity | $1.04B | $1.02B | $1.03B | $1.01B | $1.00B | $978M | $963M | $933M | $882M | $855M | $834M | $796M | $780M | $752M | $746M | $716M | |
| Liabilities + Equity | $2.30B | $2.31B | $2.33B | $2.32B | $2.33B | $2.30B | $2.31B | $2.32B | $2.29B | $2.31B | · | $2.33B | $2.32B | $2.32B | · | $2.29B | |
| Shares Outstanding | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 | 31,299,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $5M | $5M | $5M | $14M | $6M | $6M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Deferred Tax | $2M | $2M | $812.0K | $4M | $2M | $-3M | $7M | $3M | $1M | $2M | $2M | $-284.0K | $533.0K | $-1M | $-44M | $-32M | |
| Amort. of Intangibles | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Operating Cash Flow | $37M | $13M | $46M | $54M | $29M | $42M | $43M | $51M | $43M | $29M | $56M | $46M | $27M | $-4M | $-12M | $26M | |
| CapEx | $3M | $3M | $5M | $5M | $6M | $4M | $4M | $3M | $4M | $2M | $5M | $5M | $5M | $4M | $6M | $7M | |
| Investing Cash Flow | $12M | $4M | $-7M | $-5M | $-6M | $-3M | $-4M | $-3M | $-4M | $-2M | $-5M | $-5M | $-6M | $-4M | $-6M | $-91M | |
| Stock Repurchased | $6M | $37M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-37M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $0 | $0 | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Financing Cash Flow | $-46M | $-23M | $-37M | $-44M | $-27M | $-28M | $-51M | $-39M | $-44M | $-17M | $-59M | $-37M | $-20M | $5M | $12M | $47M | |
| Net Change in Cash | $2M | $-6M | $2M | $5M | $-2M | $11M | $-14M | $10M | $-5M | $10M | $-6M | $3M | $1M | $-2M | $-4M | $-20M | |
| Free Cash Flow | · | $11M | · | · | · | $38M | · | · | · | $27M | · | · | · | $-8M | · | · | |
| Levered FCF | · | $5M | · | · | · | $31M | · | · | · | $20M | · | · | · | $-16M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.5% | 57.9% | · | 49.2% | 55.0% | 55.3% | · | 56.5% | 55.3% | 55.1% | · | 55.2% | 53.7% | 52.6% | · | 55.1% | |
| Operating Margin | 10.6% | 8.0% | · | 3.5% | 11.2% | 5.0% | · | 20.8% | 14.2% | 11.2% | · | 10.0% | 8.6% | 4.3% | · | 8.8% | |
| Net Margin | 6.7% | 4.4% | · | 0.85% | 6.3% | 1.9% | · | 15.5% | 9.0% | 6.3% | · | 5.2% | 4.3% | 0.62% | · | 16.8% | |
| Pretax Margin | 9.1% | 5.8% | · | 1.3% | 8.7% | 2.4% | · | 17.8% | 11.3% | 8.1% | · | 6.7% | 5.5% | 0.83% | · | 5.7% | |
| EBITDA Margin | 10.6% | 8.0% | · | 3.5% | 11.2% | 5.0% | · | 20.8% | 14.2% | 11.2% | · | 10.0% | 8.6% | 4.3% | · | 8.8% | |
| ROA | 1.0% | 0.60% | · | 0.12% | 0.93% | 0.26% | · | 2.1% | 1.3% | 0.85% | · | 0.69% | 0.62% | 0.09% | · | 2.3% | |
| ROE | 2.3% | 1.4% | · | 0.29% | 2.3% | 0.66% | · | 5.7% | 3.6% | 2.5% | · | 2.1% | 1.9% | 0.24% | · | 6.3% | |
| ROIC | 2.6% | 1.9% | · | 0.79% | 2.7% | 1.3% | · | 6.1% | 4.3% | 3.2% | · | 3.0% | 2.8% | 1.3% | · | 9.9% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 2.3 | · | 2.1 | 2.2 | 2.3 | · | 2.3 | 2.3 | 2.2 | · | 1.7 | 1.7 | 1.9 | · | 2.8 | |
| Quick Ratio | 0.5 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.6 | 0.6 | 0.7 | · | 0.9 | |
| Interest Coverage | 4.6 | 3.6 | · | 1.6 | 4.9 | 1.9 | · | 7.1 | 4.9 | 3.6 | · | 3.0 | 2.7 | 1.2 | · | 2.8 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.5 | · | 1.5 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.27 | $32.51 | · | $32.21 | $32.04 | $31.24 | · | $29.81 | $28.17 | $27.31 | · | $25.44 | $24.93 | $24.04 | · | $22.89 | |
| Revenue / Share | $11.41 | $10.35 | · | $10.88 | $11.02 | $10.31 | · | $10.18 | $10.68 | $9.99 | · | $9.61 | $9.99 | $9.47 | · | $8.84 | |
| Cash Flow / Share | · | $0.44 | · | · | · | $1.33 | · | · | · | $0.93 | · | · | · | $-0.12 | · | · | |
| Dividend / Share | · | · | $0.00 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | |
| EPS (TTM) | $1.85 | $1.77 | · | $2.06 | $3.54 | $3.81 | · | $4.21 | $3.14 | $2.61 | · | $2.01 | $2.99 | $-3.09 | · | $-2.95 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.37B | $1.37B | · | $1.35B | $1.33B | $1.32B | · | $1.29B | $1.28B | $1.26B | · | $1.17B | $1.14B | $1.10B | · | $1.07B | |
| Net Income TTM | $56M | $55M | · | $64M | $110M | $119M | · | $132M | $99M | $82M | · | $58M | $88M | $-94M | · | $-83M | |
| Market Cap | $1.02B | $1.11B | · | $1.47B | $1.63B | $1.89B | · | $2.25B | $2.17B | $2.51B | · | $3.16B | $4.25B | $3.25B | · | $2.51B | |
| P/E | 17.7 | 20.0 | · | 22.8 | 14.7 | 15.9 | · | 17.1 | 22.1 | 30.7 | · | 50.2 | 45.4 | -33.6 | · | -27.2 | |
| P/S | 0.7 | 0.8 | · | 1.1 | 1.2 | 1.4 | · | 1.7 | 1.7 | 2.0 | · | 2.7 | 3.7 | 3.0 | · | 2.3 | |
| P/B | 1.0 | 1.1 | · | 1.5 | 1.6 | 1.9 | · | 2.4 | 2.5 | 2.9 | · | 4.0 | 5.5 | 4.3 | · | 3.5 | |
| P / Cash Flow | · | 82.2 | · | · | · | 45.5 | · | · | · | 86.1 | · | · | · | -845.0 | · | · | |
| Dividend Yield | 1.2% | 1.7% | · | 1.7% | 1.5% | 1.3% | · | 1.1% | 1.1% | 0.98% | · | 0.77% | 0.57% | 0.74% | · | 0.94% | |
| Earnings Yield | 5.7% | 5.0% | · | 4.4% | 6.8% | 6.3% | · | 5.9% | 4.5% | 3.3% | · | 2.0% | 2.2% | -3.0% | · | -3.7% | |
| Payout Ratio | · | 0.00% | · | · | · | 102.4% | · | · | · | 31.2% | · | · | · | 335.2% | · | · | |
| Annual Payout | $12M | $19M | · | $25M | $25M | $25M | · | $25M | $25M | $25M | · | $24M | $24M | $24M | · | $24M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B |
| Marża Brutto % | 54.6% | 56.1% | 54.3% | 54.6% | 56.2% |
| Marża Operacyjna % | 7.5% | 15.3% | 9.7% | 6.7% | 10.9% |
| Zysk netto | $47M | $132M | $64M | $-81M | $63M |
| Rozwodniony EPS | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 2.1 | 2.3 | 2.0 | 2.0 | 2.3 |
| Wskaźnik Szybkości | 0.8 | 0.9 | 0.8 | 0.6 | 0.9 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $151M | $154M | $106M | $12M | $97M |
Właściciele instytucjonalni (13F) 265 emitentów · $1.3B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
265
Wartość posiadanych akcji
$1.3B
Nowe pozycje
42
Zamknięte pozycje
29
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 42 (0 vs poprzedni kw.) | 29 (-26 vs poprzedni kw.) | 85 (-10 vs poprzedni kw.) | 80 (+12 vs poprzedni kw.) | +326K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $157 782 788 | 4 820 739 | 12,52% | Akcje |
| VANGUARD GROUP INC | $149 588 224 | 3 684 439 | 11,87% | Akcje |
| EARNEST PARTNERS LLC | $81 998 305 | 2 505 295 | 6,50% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $71 638 148 | 2 188 761 | 5,68% | Akcje |
| FULLER & THALER ASSET MANAGEMENT, INC. | $51 710 696 | 1 579 917 | 4,10% | Akcje |
| STATE STREET CORP | $46 393 728 | 1 417 468 | 3,68% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $44 372 977 | 1 355 728 | 3,52% | Akcje |
| BANK OF AMERICA CORP /DE/ | $43 904 317 | 1 341 409 | 3,48% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $43 121 568 | 1 317 370 | 3,42% | Akcje |
| SEI INVESTMENTS CO | $32 342 166 | 988 151 | 2,57% | Akcje |
| Invenomic Capital Management LP | $27 563 962 | 842 162 | 2,19% | Akcje |
| Capital Research Global Investors | $26 957 606 | 823 636 | 2,14% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $25 866 562 | 790 138 | 2,05% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $23 859 384 | 728 976 | 1,89% | Akcje |
| Allspring Global Investments Holdings, LLC | $20 260 323 | 618 447 | 1,61% | Akcje |
| COOKE & BIELER LP | $18 770 590 | 573 498 | 1,49% | Akcje |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $17 616 759 | 538 245 | 1,40% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $15 608 446 | 476 885 | 1,24% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15 416 550 | 471 022 | 1,22% | Akcje |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $14 445 802 | 441 361 | 1,15% | Akcje |
| GOLDMAN SACHS GROUP INC | $14 297 447 | 436 830 | 1,13% | Akcje |
| AMERIPRISE FINANCIAL INC | $14 279 731 | 436 289 | 1,13% | Akcje |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $12 132 684 | 370 690 | 0,96% | Akcje |
| NORTHERN TRUST CORP | $11 499 980 | 351 359 | 0,91% | Akcje |
| GLENMEDE TRUST CO NA | $10 594 733 | 323 701 | 0,84% | Akcje |
| Glenmede Investment Management, LP | $10 447 055 | 222 136 | 0,83% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $10 211 062 | 310 754 | 0,81% | Akcje |
| Bank of New York Mellon Corp | $9 531 081 | 291 203 | 0,76% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $9 194 380 | 280 916 | 0,73% | Akcje |
| Tributary Capital Management, LLC | $8 417 501 | 257 180 | 0,67% | Akcje |
| MORGAN STANLEY | $8 110 133 | 247 788 | 0,64% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $7 515 528 | 229 622 | 0,60% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $6 903 477 | 210 922 | 0,55% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $6 712 427 | 205 273 | 0,53% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $6 557 946 | 200 365 | 0,52% | Akcje |
| Trexquant Investment LP | $6 490 457 | 198 303 | 0,51% | Akcje |
| MARSHALL WACE, LLP | $5 742 610 | 175 454 | 0,46% | Akcje |
| Invesco Ltd. | $5 358 948 | 163 732 | 0,43% | Akcje |
| Legal & General Group Plc | $5 327 265 | 162 764 | 0,42% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $5 168 711 | 143 775 | 0,41% | Akcje |
| UBS Group AG | $4 669 098 | 142 655 | 0,37% | Akcje |
| CITADEL ADVISORS LLC | $4 656 268 | 142 263 | 0,37% | Akcje |
| TWO SIGMA ADVISERS, LP | $4 636 520 | 114 200 | 0,37% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $4 473 102 | 136 667 | 0,35% | Akcje |
| Dana Investment Advisors, Inc. | $4 314 763 | 131 829 | 0,34% | Akcje |
| ALGERT GLOBAL LLC | $4 297 220 | 131 293 | 0,34% | Akcje |
| JANE STREET GROUP, LLC | $4 074 099 | 124 476 | 0,32% | Akcje |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $4 045 927 | 114 421 | 0,32% | Akcje |
| WELLS FARGO & COMPANY/MN | $3 765 872 | 115 059 | 0,30% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $3 751 153 | 114 609 | 0,30% | Akcje |
Aktywiści i właściciele 5%+ 9 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Scopia Capital Management LP (2), Scopia Management, Inc. (2), Matthew Sirovich (2), Jeremy Mindich (2) ×5 zgłoszenia | 22 sierpnia 2018 | · | Pierwotne zgłoszenie | · | SEC |
| SCOPIA CAPITAL MANAGEMENT LP, SCOPIA MANAGEMENT, INC., MATTHEW SIROVICH, JEREMY MINDICH ×2 zgłoszenia | 6 maja 2016 | · | Pierwotne zgłoszenie | · | SEC |
| SCOPIA PX LLC, SCOPIA PARTNERS LLC, SCOPIA HEALTH CARE LLC, SCOPIA WINDMILL FUND LP, SCOPIA INTERNATIONAL MASTER FUND LP, SCOPIA PX INTERNATIONAL MASTER FUND LP, SCOPIA HEALTH CARE INTERNATIONAL MASTER FUND LP, SCOPIA CAPITAL GP LLC, SCOPIA CAPITAL MANAGEMENT LP, SCOPIA MANAGEMENT, INC., MATTHEW SIROVICH, JEREMY MINDICH ×3 zgłoszenia | 30 marca 2016 | · | Pierwotne zgłoszenie | · | SEC |
| COPPERSMITH CAPITAL MANAGEMENT, LLC, JEROME J. LANDE, CRAIG ROSENBLUM ×4 zgłoszenia | 19 lutego 2016 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 16 grudnia 2013 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 16 lipca 2004 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 29 października 2003 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 6 maja 2003 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 23 stycznia 2003 | · | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 60 insiderów · 38 dyrektorzy generalni · 21 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Pat Beyer | President & CEO | 1 kwietnia 2026 A | 10 807 | 0 | 0 | $0 |
| Curt R Hartman | President and CEO | 7 listopada 2024 M | 9 996 | 0 | 0 | $0 |
| Joseph J Corasanti | Former President & CEO | 30 lipca 2014 M | 156 356 | 0 | 0 | $0 |
| John E Gallagher | Executive Vice President & CFO | 15 lipca 2026 A | · | 0 | 0 | $0 |
| Todd W. Garner | Executive Vice President & CFO | 6 listopada 2025 S | 1 836 | 0 | 1 | $-150 500 |
| Robert D Shallish JR | EVP, Finance, CFO | 31 grudnia 2014 A | 53 876 | 0 | 0 | $0 |
| Stanley W Peters III | President AS and AET | 14 czerwca 2024 M | 63 | 0 | 0 | $0 |
| Gerald G Woodard | PRESIDENT LINVATEC | 30 maja 2007 M | 0 | 0 | 0 | $0 |
| David R Murray | President Electrosurgery | 17 maja 2007 A | 269 | 0 | 0 | $0 |
| Eugene Starr | President-Electrosurgery | 5 stycznia 2004 A | 787 | 0 | 0 | $0 |
| Matthew Schabacker | VP GM Advanced Surgical | 2 marca 2026 A | · | 0 | 0 | $0 |
| Andrew James Moller | VP Corporate Controller | 2 marca 2026 A | · | 0 | 0 | $0 |
| Hollie K Foust | General Counsel & Corp Sec | 2 marca 2026 A | 2 886 | 0 | 0 | $0 |
| John D. Ferrell | Executive Vice President - HR | 2 marca 2026 A | 702 | 0 | 0 | $0 |
| Brent Lalomia | Executive VP RA, QA | 2 marca 2026 A | 915 | 0 | 0 | $0 |
| Johonna Marie Pelletier | Treasurer and VP, Tax | 2 marca 2026 A | 1 317 | 0 | 0 | $0 |
| Peter K Shagory | EVP, STRAT & CORP DEVT | 2 marca 2026 A | 3 897 | 0 | 0 | $0 |
| Richard Glaze | Chief Information Officer | 21 listopada 2025 S | 0 | 0 | 1 | $-10 591 |
| Edward A. Clifford | VP Global Manufacturing | 3 marca 2025 A | 378 | 0 | 0 | $0 |
| Stephan Epinette | VP GM International | 3 marca 2025 A | · | 0 | 0 | $0 |
| Heather L Cohen | EVP & Chief HR & Legal Officer | 28 marca 2024 A | 35 992 | 0 | 0 | $0 |
| Terence M Berge | VP-Corporate Controller | 1 marca 2024 A | 1 004 | 0 | 0 | $0 |
| Daniel S Jonas | Special Counsel & Corp Secy | 28 kwietnia 2023 M | 13 462 | 0 | 0 | $0 |
| Jaclyn Peterson | VP of Mfg. & Adv. Engineering | 1 marca 2023 M | 739 | 0 | 0 | $0 |
| John Jed Kennedy | Group Executive Vice President | 3 marca 2022 M | 9 855 | 0 | 0 | $0 |
| Wilfredo Ruiz-Caban | EVP QA, RA and Operations | 30 czerwca 2020 A | 3 975 | 0 | 0 | $0 |
| Nathan Folkert | VP GM Orthopedics | 2 marca 2020 A | 2 280 | 0 | 0 | $0 |
| Mark D Snyder | EVP Mfg. Ops & Business System | 31 marca 2016 D | 20 130 | 0 | 0 | $0 |
| Gregory Renard Jones | EVP-Corporate QA/RA | 30 września 2015 A | 15 465 | 0 | 0 | $0 |
| Joseph G Darling | EVP, Commercial Operations | 2 lutego 2015 M | 16 837 | 0 | 0 | $0 |
| William Abraham | EVP-Business Development | 30 września 2014 M | 4 872 | 0 | 0 | $0 |
| David Allen Johnson | VP - Global Operations | 25 lutego 2010 M | 468 | 0 | 0 | $0 |
| Jane E Metcalf | VP CORPORATE REG. AFFAIRS | 1 czerwca 2008 A | 1 634 | 0 | 0 | $0 |
| Alexander Jones | VP/Corporate Sales | 29 czerwca 2007 A | 5 451 | 0 | 0 | $0 |
| Thomas Acey | SECRETARY & TREASURER | 13 czerwca 2007 A | 3 475 | 0 | 0 | $0 |
| Frank R Williams | VICE PRESIDENT | 5 czerwca 2007 M | 4 926 | 0 | 0 | $0 |
| Dennis M Werger | Gen. Man. of CONMED Endo Tech | 17 maja 2007 A | 269 | 0 | 0 | $0 |
| John J Stotts | VICE PRESIDENT | 17 maja 2007 A | 45 275 | 0 | 0 | $0 |
| Kim Kelderman | Dyrektor | 8 września 2026 M | 500 | 0 | 0 | $0 |
| Celine Christine Martin | Dyrektor | 1 lipca 2026 A | · | 0 | 0 | $0 |
| Jeffrey B. Mirviss | Dyrektor | 1 lipca 2026 A | · | 0 | 0 | $0 |
| Laverne H Council | Dyrektor | 2 czerwca 2026 M | 4 716 | 0 | 0 | $0 |
| Barbara J Schwarzentraub | Dyrektor | 2 czerwca 2026 M | 5 012 | 0 | 0 | $0 |
| Mark Kaye | Dyrektor | 2 czerwca 2026 M | 820 | 0 | 0 | $0 |
| Charles Farkas | Dyrektor | 2 czerwca 2026 M | 15 527 | 0 | 0 | $0 |
| David M Bronson | Dyrektor | 2 czerwca 2026 M | 17 909 | 0 | 0 | $0 |
| Martha Goldberg Aronson | Dyrektor | 3 czerwca 2025 M | 12 391 | 0 | 0 | $0 |
| Brian Concannon | Dyrektor | 3 czerwca 2025 M | 10 116 | 0 | 0 | $0 |
| John L Workman | Dyrektor | 20 maja 2025 M | 20 891 | 0 | 0 | $0 |
| Jerome J. Lande | Dyrektor | 31 maja 2024 M | 3 856 | 0 | 0 | $0 |
| Mark E Tryniski | Dyrektor | 1 czerwca 2022 M | 9 108 | 0 | 0 | $0 |
| Dirk Kuyper | Dyrektor | 2 sierpnia 2019 M | 5 000 | 0 | 0 | $0 |
| Jo Ann Golden | Dyrektor | 1 czerwca 2018 M | 9 949 | 0 | 0 | $0 |
| Bruce Daniels | Dyrektor | 30 lipca 2014 S | 5 000 | 0 | 0 | $0 |
| Eugene R Corasanti | Dyrektor | 23 lipca 2014 M | 84 558 | 0 | 0 | $0 |
| Stuart J Schwartz | Dyrektor | 1 czerwca 2014 M | 10 600 | 0 | 0 | $0 |
| William Matthews | Dyrektor | 18 maja 2007 A | 5 500 | 0 | 0 | $0 |
| Robert Remmell | Dyrektor | 19 maja 2004 A | 675 | 0 | 0 | $0 |
| Luke A Pomilio | · | 1 marca 2018 M | 0 | 0 | 0 | $0 |
| Stephen Mandia | · | 29 maja 2015 S | 1 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 51 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,58% | 23 645 NS | 31 lipca 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,87% | 36 511 NS | 31 lipca 2026 | N-PORT |
| EPSB · Harbor ETF Trust | 0,81% | 838 NS | 31 lipca 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,75% | 28 525 SH | 5 października 2026 | Dziennie |
| HAPS · Harbor ETF Trust | 0,72% | 26 439 NS | 31 lipca 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,45% | 133 262 NS | 31 lipca 2026 | N-PORT |
| IHI · iShares Trust | 0,21% | 143 754 SH | 11 września 2026 | Dziennie |
| ROSC · Lattice Strategies Trust | 0,18% | 2 398 NS | 31 lipca 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,17% | 6 314 NS | 31 lipca 2026 | N-PORT |
| ESSC · Strategy Shares | 0,17% | 1 295 NS | 31 lipca 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 71 113 SH | 5 października 2026 | Dziennie |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 14 734 NS | 31 lipca 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,11% | 63 889 SH | 19 sierpnia 2026 | Dziennie |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,09% | 4 827 SH | 5 października 2026 | Dziennie |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,09% | 37 291 SH | 5 października 2026 | Dziennie |
| VFVA · VANGUARD WELLINGTON FUND | 0,08% | 20 212 SH | 19 sierpnia 2026 | Dziennie |
| DFSV · Dimensional ETF Trust | 0,07% | 124 576 NS | 31 lipca 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,07% | 178 NS | 31 lipca 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,06% | 26 474 SH | 19 sierpnia 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 7 846 NS | 31 lipca 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 104 975 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,05% | 791 772 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,05% | 14 710 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 177 248 SH | 19 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,02% | 69 686 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 14 669 NS | 31 lipca 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,02% | 437 495 SH | 19 sierpnia 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,01% | 1 673 NS | 31 lipca 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,01% | 42 499 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 1 911 SH | 10 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 347 035 SH | 19 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,01% | 688 644 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 90 678 SH | 19 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,01% | 2 844 NS | 31 lipca 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 15 120 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 43 369 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 8 067 SH | 11 września 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 18 466 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 4 730 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 958 140 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 20 172 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 626 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,00% | 6 847 SH | 19 sierpnia 2026 | Dziennie |
| IJR · iShares Trust | · | 1 836 934 SH | 10 września 2026 | Dziennie |
| IJS · iShares Trust | · | 268 002 SH | 8 września 2026 | Dziennie |
| IWN · iShares Trust | · | 289 600 SH | 11 września 2026 | Dziennie |
| XJR · iShares Trust | · | 4 179 SH | 31 sierpnia 2026 | Dziennie |
| SVAL · iShares Trust | · | 16 593 SH | 3 września 2026 | Dziennie |
| ISCB · iShares Trust | · | 1 278 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 6 330 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 33 440 SH | 11 września 2026 | Dziennie |
CNMD Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 12 analityków
TRZYMAJ
Średni cel
$45.00
+1,2%
0 0,0%
Mocne kupno
0 0,0%
Kup
8 66,7%
Trzymaj
2 16,7%
Sprzedaj
2 16,7%
Mocna sprzedaż
12-miesięczny cel cenowy
6 analityków · 2026-10-03Średnia cel $45.50 +2,3%
Teraz
Aktualna cena $44.48
Niski$43.00
Średnia$45.50
Wysoki$49.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CNMD | $1.27B | 26.9 | 5.2% | 3.4% | 4.6% | 54.6% |
| LMAT | $1.85B | 32.2 | 13.5% | 23.1% | 15.3% | 71.5% |
| ATEC | $3.16B | -21.9 | 24.9% | -18.8% | -792.1% | 69.6% |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| OMCL | $2.04B | 1132.5 | 6.5% | 0.17% | 0.16% | 42.5% |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| TNDM | $1.50B | -7.2 | 7.9% | -20.2% | -141.9% | 53.8% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Lip 29, 2026